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Since 2007, the World Health Organization has recommended that in countries with generalized HIV 
epidemics, HIV testing and counselling should be offered to all adults and adolescents seen in a 
health facility (1). This recommendation had been policy in Uganda since 2005 (2).  However, 
evidence suggests that translation of this policy to practice in real-world settings has been patchy 
and that missed opportunities with HIV testing in the inpatient setting are still contributing to HIV 
related deaths (3,4).    
In this issue, Cummings and Colleagues (5) assessed the effectiveness of a multi-modal quality 
improvement programme on HIV status assessment in western Uganda. The quality improvement 
(QI) programme included a one-week instructional course on the early recognition of severe illness 
and HIV status assessment as an important part of management of sick individuals, followed by site-
specific QI interventions (audits, performance assessments, and mentoring). HIV status assessment 
in adults and adolescents admitted to medical wards was assessed before and after the intervention. 
Of the total 5,759 hospitalised patients evaluated, less than half (42.6%) had their HIV status 
assessed. Although HIV status assessment was higher post-intervention (44.8%) than pre-
intervention (36.5%), the difference was not statistically significant. There was inconsistency in 
effect between the sites, and the facility with the poorest performance prior to the intervention did 
achieve a significant improvement in HIV status assessment, although this remained below 50%. The 
importance of proper assessment of HIV status was highlighted in this study by the observations that 
HIV prevalence was four times higher than that of the general population at 16% and in-hospital 
mortality was also substantially higher in HIV-positive patients. 
Data on HIV test offer were not reported, making it difficult to differentiate between failure to offer 
HIV testing and refusal of HIV testing in the majority of individuals whose HIV status was not 
established. As a result, it is difficult to comment as to whether the QI programme was intrinsically 
ineffective or the fidelity of implementation was poor. It was also not possible to ascertain the 
number of new testers amongst those whose status was reported as HIV-positive. The underlying 
diagnoses for the severe illness conditions resulting in higher mortality in HIV-positive individuals 
were also not reported. As neither antiretroviral treatment status nor CD4 counts were reported in 
those ascertained to be HIV-positive, one could not establish the contribution of late presentation in 
this study to the observed higher morbidity and mortality in HIV-positive individuals (6). There is also 
the increased risk that those unaware of their HIV-positive status would continue to transmit the 
virus.  It would be interesting to know whether the QI intervention did lead to other positive 
changes, as this might suggest that there was insufficient focus on HIV assessment within the QI 
programme or that there were specific barriers to improving HIV testing. The authors allude to some 
of these limitations. 
Informing all patients that an HIV test would be routinely added to their investigations may improve 
testing rates by reducing the amount of time spent on pre-test counselling. Signs advertising this 
approach should be displayed in strategic places at the point of admission and on the wards. Using 
point of care HIV tests that provide results in one minute (INSTI™ Rapid HIV Test; bioLytical 
Laboratories, BC, Canada), rather than the usual 20 minutes could also encourage the offer of a test 
by health care providers. 
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